Invention Grant
US09095506B2 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
有权
可生物降解的α-2激动剂聚合物植入物及其治疗用途
- Patent Title: Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
- Patent Title (中): 可生物降解的α-2激动剂聚合物植入物及其治疗用途
-
Application No.: US12272548Application Date: 2008-11-17
-
Publication No.: US09095506B2Publication Date: 2015-08-04
- Inventor: Lon T. Spada , Alazar N. Ghebremeskel , Michael R. Robinson
- Applicant: Lon T. Spada , Alazar N. Ghebremeskel , Michael R. Robinson
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Laura L. Wine; Joel B. German; Debra D. Condino
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/498 ; A61K47/34
Abstract:
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants can be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, including reduction of an elevated intraocular pressure.
Public/Granted literature
- US20100124565A1 BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF Public/Granted day:2010-05-20
Information query
